Protega Pharms Drug Patent Portfolio
Protega Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Protega Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10314788 | Pharmaceutical compositions configured to deter dosage form splitting | 12 Aug, 2028 | Active |
| US7955619 | Abuse resistant drugs, method of use and method of making | 12 Aug, 2028 | Active |
Protega Pharms's Family Patents
Protega Pharms drugs have patent protection in a total of 10 countries. It has a significant patent presence in the US with 60.9% of its patents being US patents. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
Protega Pharms Drug List
Given below is the complete list of Protega Pharms's drugs and the patents protecting them.
1. Roxybond
Roxybond is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10314788 | Pharmaceutical compositions configured to deter dosage form splitting |
12 Aug, 2028
(3 years from now)
| Active |
| US7955619 | Abuse resistant drugs, method of use and method of making |
12 Aug, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Roxybond's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List